本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Black Diamond Therapeutics, Inc.

1.88
+0.16009.30%
盘后1.81-0.0700-3.72%19:59 EDT
成交量:2,240.47万
成交额:4,339.19万
市值:1.07亿
市盈率:-1.48
高:2.10
开:1.83
低:1.75
收:1.72
数据加载中...

公司资料

公司名字:
Black Diamond Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2014
员工人数:
24
公司地址:
One Main Street,14th Floor,Cambridge,Massachusetts,United States
邮编:
02142
电话:
传真:
- -
简介:
Black Diamond Therapeutics, Inc.于2014年12月在特拉华州成立。该公司是一家临床阶段的肿瘤学公司,专注于开发用于治疗基因定义肿瘤患者的MasterKey疗法。该公司的目标是基因定义癌症患者中不存在药物的致癌驱动基因突变。

董事

名称
职位
Bradley Bolzon
Director and Chairman of the Board of Director
David M. Epstein
President, Chief Executive Officer and Director
Alexander Mayweg
Director
Ali Behbahani
Director
Garry E. Menzel
Director
Rajeev Shah
Director
Samarth Kulkarni
Director

股东

名称
职位
David M. Epstein
President, Chief Executive Officer and Director
Brent Hatzis Schoch
Chief Operating Officer and General Counsel
Karsten Witt
Senior Vice President, Clinical Development
Thomas Leggett
Chief Financial Officer
Christopher D. Roberts
Chief Scientific Officer
Elizabeth Buck
Executive Vice President, Discovery and Translational Services